136 related articles for article (PubMed ID: 30638990)
1. Probucol ameliorates hepatic stellate cell activation and autophagy is associated with farnesoid X receptor.
Yang R; Hu Z; Zhang P; Wu S; Song Z; Shen X; Wei Z
J Pharmacol Sci; 2019 Feb; 139(2):120-128. PubMed ID: 30638990
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction.
Xu W; Lu C; Zhang F; Shao J; Yao S; Zheng S
FEBS J; 2017 Jan; 284(1):114-133. PubMed ID: 27896916
[TBL] [Abstract][Full Text] [Related]
3. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
4. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.
Zhou J; Cui S; He Q; Guo Y; Pan X; Zhang P; Huang N; Ge C; Wang G; Gonzalez FJ; Wang H; Hao H
Nat Commun; 2020 Jan; 11(1):240. PubMed ID: 31932588
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin restricts hepatic stellate cell contraction via an FXR-S1PR2-dependent mechanism.
Xu W; Lu C; Zhang F; Shao J; Zheng S
IUBMB Life; 2016 May; 68(5):376-87. PubMed ID: 27027402
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotection of auraptene from peels of citrus fruits against thioacetamide-induced hepatic fibrosis in mice by activating farnesoid X receptor.
Gao X; Wang C; Ning C; Liu K; Wang X; Liu Z; Sun H; Ma X; Sun P; Meng Q
Food Funct; 2018 May; 9(5):2684-2694. PubMed ID: 29721568
[TBL] [Abstract][Full Text] [Related]
9. Obeticholic acid prevents carbon tetrachloride-induced liver fibrosis through interaction between farnesoid X receptor and Smad3.
Fan YY; Ding W; Zhang C; Fu L; Xu DX; Chen X
Int Immunopharmacol; 2019 Dec; 77():105911. PubMed ID: 31671330
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts.
Fickert P; Fuchsbichler A; Moustafa T; Wagner M; Zollner G; Halilbasic E; Stöger U; Arrese M; Pizarro M; Solís N; Carrasco G; Caligiuri A; Sombetzki M; Reisinger E; Tsybrovskyy O; Zatloukal K; Denk H; Jaeschke H; Pinzani M; Trauner M
Am J Pathol; 2009 Dec; 175(6):2392-405. PubMed ID: 19910507
[TBL] [Abstract][Full Text] [Related]
11. 20
Song J; Cui ZY; Lian LH; Han X; Hou LS; Wang G; Gao L; Zhu Y; Jiang YC; Dou JY; Hu ZH; Zhao YQ; Nan JX; Wu YL
J Agric Food Chem; 2020 Aug; 68(31):8195-8204. PubMed ID: 32662640
[TBL] [Abstract][Full Text] [Related]
12. The antioxidant effect of β-caryophyllene protects rat liver from carbon tetrachloride-induced fibrosis by inhibiting hepatic stellate cell activation.
Calleja MA; Vieites JM; Montero-Meléndez T; Torres MI; Faus MJ; Gil A; Suárez A
Br J Nutr; 2013 Feb; 109(3):394-401. PubMed ID: 22717234
[TBL] [Abstract][Full Text] [Related]
13. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
[TBL] [Abstract][Full Text] [Related]
14. Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell.
Zhang Z; Zhao S; Yao Z; Wang L; Shao J; Chen A; Zhang F; Zheng S
Redox Biol; 2017 Apr; 11():322-334. PubMed ID: 28038427
[TBL] [Abstract][Full Text] [Related]
15. SHP-dependent and -independent induction of peroxisome proliferator-activated receptor-γ by the bile acid sensor farnesoid X receptor counter-regulates the pro-inflammatory phenotype of liver myofibroblasts.
Renga B; Mencarelli A; Migliorati M; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
Inflamm Res; 2011 Jun; 60(6):577-87. PubMed ID: 21279417
[TBL] [Abstract][Full Text] [Related]
16. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
[TBL] [Abstract][Full Text] [Related]
17. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity.
Manley S; Ni HM; Williams JA; Kong B; DiTacchio L; Guo G; Ding WX
Redox Biol; 2014; 2():991-1002. PubMed ID: 25460735
[TBL] [Abstract][Full Text] [Related]
19. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
20. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]